Great to spend time with @TrialLibrary founder Hala Borno tonight. Her and I doing a lil game planning for our panel @hr_transform tomorrow. Love what she’s building at TL!

@DarioAmodei also added that he’d like to see AI play a role in one of the big discoveries like CRISPR, CAR-T… and play a part in clinical trials and drugs getting to market faster. Articulating clearly some of our thesis around AI x health at @Lux_Capital, including in companies like @TrialLibrary and @bluenote_ai

Congratulations to the @TrialLibrary team on closing their Series A! See the exclusive in @endpts below. We are thrilled to be backers @OverwaterVC! endpoints.news/trial-library…

Delighted to also welcome @SempervirensFnd and @sanofi Ventures to the cap table, with insiders also doubling down on @TrialLibrary! More from @nyeungs in @endpts this morning: endpoints.news/trial-library…

Huge congrats to the incredible @TrialLibrary team on their Series A raise! As day one backers, we have had the privilege of observing the company’s high velocity growth and couldn’t be more excited about this next chapter. The best is yet to come!

NEWS 🚨 Congrats to the @TrialLibrary team on their Series A! Their work is already making a significant impact by redefining how providers and patients access life-changing therapies.

Hiring Alert: @TrialLibrary, a standout @OverwaterVC portfolio company, is hiring a Chief Product Officer. They’re the leading AI solution for trial recruitment and retention, on a mission to expand access to cancer precision medicine. Apply here: jobs.lever.co/triallibrary/e…

What are real world #mCRPC outcomes with Lu-PSMA therapy in a racially diverse patient population at @WinshipAtEmory? 🔎Discussing our @ASCO #GU25 abstract with @bilenma @MargoGerke23 as well as previous and emerging Lu-PSMA trials with @GUOncologyNow. Check out our discussion below! 📌guoncologynow.com/post/real-… Key real world takeaways of Lu-PSMA treatment in mCRPC w/ 84 pts (mean age 71.5): ✅12m OS 84.4% (81.4% non-white vs 88.3% white) ✅ 12m PFS 41.9% (42.7% non-white vs 41.5% white) ✅ 50% of patients had PSA50 response (56.1% non-white vs 43.9% white) ☝️We need to do more as a community to improve diversity in clinical trials #diversity #prostatecancer @PCFnews @AmericanCancer @TrialLibrary @PCF_Science @urotoday @OncoAlert @oncodaily @TargetedOnc @OncoReporte @OncLive

Improving Diversity in Clinical Trials? @GUASCO #GU25 @billdahutmd @AmericanCancer outlines an inspiring vision for collaboration and urgent need to improve diversity in clinical research 📌Among 70 Ph III prostate trials, 96% were white 📌 19% trials did not report race/ethnicity 🔎 We need to identify barriers to enrollment 🔎 We, as physicians, need to ASK and educate patients on trials As a community, we need to do more to ensure all patients, regardless of background, have access to cutting-edge trials and care @Asco @OncoAlert @GUOncologyNow @urotoday @TargetedOnc @OncoReporte @OncLive @ThePCCTC @TrialLibrary #equity #diversity

Exciting work ahead to get more Black men on clinical trials for prostate cancer. Looking forward to seeing what @TrialLibrary, @ThePCCTC, and @AmericanCancer can do together!

We are thrilled to announce a monumental new collaboration with @AmericanCancer and @TrialLibrary to support a national initiative to accelerate the recruitment of Black patients to #ProstateCancer clinical trials. Full press release: pressroom.cancer.org/release…

Bring on the chaos baby!!! 🤪

ME TOO! Founders like @_KateRyder , @ellenjdasilva , and Hala Borno of @TrialLibrary ( amazing VCs like @AlyssaJoyJaffee) inspired me to add a third baby into the mix despite an already very full plate! Such a privilege to work with/learn from these incredible powerhouses

At @OverwaterVC, we believe there are major gaps within women's health and breakthrough tech can help solve these problems. We've partnered with a number of companies determined to build solutions here. Examples: @OvertureLife, @GametoGen @GetTinyHealth, @conceive, Adaptyx Bio, Tender, Olio Labs, @RTHM_Health, and @TrialLibrary. If you're building a company in women's health, please reach out!

One of our portfolio companies @overwatervc, @TrialLibrary, has launched their new and improved website. They're focused on advancing health equity by expanding access to cancer precision medicine. They tackle first and last mile of cancer care triallibrary.com

We're excited to partner with @TrialLibrary on this initiative to advance access to clinical trials in community oncology settings! This innovative platform, is a significant step forward in the realm of oncology treatment clinical trials. lnkd.in/gUv6fEJ4

Shoutout to Dr. @HalaBorno of @TrialLibrary for sharing her story at #Lead2023. 🤩💉🌎

Powerful and inspiring vignette from Dr @HalaBorno discussing her why and drive to be a leader in #oncology As a refugee mourning the conflict in her country to becoming an oncologist and then a CEO of her own company @TrialLibrary Dr Borno is driven by #justice #healthequity

Built for clinicians, by clinicians. At #ASCO23, we are showcasing our latest technology platform designed for seamless clinical trial discovery at the point of care. Stop by our booth (#IH11) to hear about the comprehensive support @TrialLibrary offers to oncology practices.

TOI is pleased to announce our partnership with @TrialLibrary to improve patient access to #clinicaltrials! The partnership is a significant step forward in providing cutting-edge care to patients in the communities we serve, and beyond. Read the release: ow.ly/NuU150OuUKC